Please login to the form below

Not currently logged in
Email:
Password:

Welcome to PMEA


PMEA: Recognising excellence in improving patient outcomes

What is the PMEA programme?

PMEA rewards responsible customer-centric business practices that ensure treatments and advice provide patients with meaningful outcomes.

It reflects the dynamic healthcare environment and the industry’s development of new, intelligent ways to improve patient care and outcomes and provide greater value for healthcare providers and payers.

Each year the categories and programme are scrutinised to ensure that PMEA continues to be specifically designed to recognise and commend excellence, best practice and innovation in European, international and local markets. For 2020, the judging criteria and categories have once again been refined.

Entry period
PMEA 2020 entry period is from January 2019 – June 2020 unless otherwise stated in the category description.

PMEA 2020 aims to…

1. Recognise work that delivers clearly identifiable benefits and improved outcomes for patients and societal value.

2. Recognise the value of responsible business practice that improves:

  • Standards of clinical practice
  • Provision of healthcare
  • Access to medical treatment or services
  • Uptake of treatment
  • Adherence and compliance with treatment
  • Coordination and delivery of services
  • Treatment benefits
  • Support for independence and management of risk

3. Identify and recognise the talented organisations behind the work.

4. Create an environment where success is valued and commended.

Why Enter PMEA?

Good work shouldn’t go unrecognised. Don’t miss your chance to be singled out for excellence in improving patient outcomes by a panel of experienced, independent industry judges. Being recognised through the PMEA programme is regarded as a significant achievement for the teams, companies, agencies and consultancies behind the initiatives.

Success at PMEA can be a key driver for business growth and for building morale with internal and external stakeholders alike.

Who can enter?

  • European, international or UK pharmaceutical, biotech, ethical, life science, OTC and medical device/diagnostic companies
  • Healthcare agencies and consultancies, based in Europe, international or UK
  • Management consultants acting on behalf (and with the full authorisation) of the client pharmaceutical company
  • Patient associations and charities
  • Trade organisations and professional bodies.

“Takeda’s commitment is to patients, to enable change for patients through its medicines and programmes. We were extremely happy to have won the Company of the Year for the second year in a row. This is testament to the progress we’ve made and culture we’re building within the new Takeda organisation, and to the quality and commitment of our people. I’m personally extremely proud of the recognition Takeda has achieved through PMEA in 2018 and 2019 and I continue to encourage and empower our people to be ambitious and lead in everything they do, with a patient-centred mindset, that is the Takeda ethos. We hope we can continue our success with PMEA in the future.”
Jon Neal, Managing Director, Takeda UK & Ireland

Sponsors

Key dates

Entry deadline 27 August 2020
Extended entry deadline 3 September 2020*
*additional fee applies
Judging Day 1 October 2020
Company of the Year Interviews 22 October 2020
PMEA Event 25 November 2020